Cargando…

Liquid Chromatographic Determination of Flavoxate HCl in Pharmaceutical Formulation

The objective of the study was to develop a high performance liquid chromatography (HPLC) method using ultra violet (UV) detection for the determination of flavoxate HCl in bulk and solid dosage forms by using ibuprofen as the internal standard. Eclipse C18 column (150 mm × 4.6 mm, 5 μm) was used as...

Descripción completa

Detalles Bibliográficos
Autor principal: Attimarad, M
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2964756/
https://www.ncbi.nlm.nih.gov/pubmed/21042486
http://dx.doi.org/10.4103/0975-1483.66787
_version_ 1782189426301992960
author Attimarad, M
author_facet Attimarad, M
author_sort Attimarad, M
collection PubMed
description The objective of the study was to develop a high performance liquid chromatography (HPLC) method using ultra violet (UV) detection for the determination of flavoxate HCl in bulk and solid dosage forms by using ibuprofen as the internal standard. Eclipse C18 column (150 mm × 4.6 mm, 5 μm) was used as the stationary phase with a mixture of acetonitrile : 0.1% formic acid in water (75: 25 v/v) as the mobile phase. The response of the drug was linear in the concentration range of 1 – 250 μg/ml. Limit of detection and Limit of quantification were found to be 0.23 μg/ml and 0.69 μg/ml, respectively. The percentage of recovery ranged between 97.4 and 101.3%. The factors affecting column separation of the analyte were studied. The results demonstrated that this method is reliable, reproducible, and suitable for routine quantitative use.
format Text
id pubmed-2964756
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-29647562010-11-01 Liquid Chromatographic Determination of Flavoxate HCl in Pharmaceutical Formulation Attimarad, M J Young Pharm Pharm Analysis The objective of the study was to develop a high performance liquid chromatography (HPLC) method using ultra violet (UV) detection for the determination of flavoxate HCl in bulk and solid dosage forms by using ibuprofen as the internal standard. Eclipse C18 column (150 mm × 4.6 mm, 5 μm) was used as the stationary phase with a mixture of acetonitrile : 0.1% formic acid in water (75: 25 v/v) as the mobile phase. The response of the drug was linear in the concentration range of 1 – 250 μg/ml. Limit of detection and Limit of quantification were found to be 0.23 μg/ml and 0.69 μg/ml, respectively. The percentage of recovery ranged between 97.4 and 101.3%. The factors affecting column separation of the analyte were studied. The results demonstrated that this method is reliable, reproducible, and suitable for routine quantitative use. Medknow Publications 2010 /pmc/articles/PMC2964756/ /pubmed/21042486 http://dx.doi.org/10.4103/0975-1483.66787 Text en © Journal of Young Pharmacists http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Pharm Analysis
Attimarad, M
Liquid Chromatographic Determination of Flavoxate HCl in Pharmaceutical Formulation
title Liquid Chromatographic Determination of Flavoxate HCl in Pharmaceutical Formulation
title_full Liquid Chromatographic Determination of Flavoxate HCl in Pharmaceutical Formulation
title_fullStr Liquid Chromatographic Determination of Flavoxate HCl in Pharmaceutical Formulation
title_full_unstemmed Liquid Chromatographic Determination of Flavoxate HCl in Pharmaceutical Formulation
title_short Liquid Chromatographic Determination of Flavoxate HCl in Pharmaceutical Formulation
title_sort liquid chromatographic determination of flavoxate hcl in pharmaceutical formulation
topic Pharm Analysis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2964756/
https://www.ncbi.nlm.nih.gov/pubmed/21042486
http://dx.doi.org/10.4103/0975-1483.66787
work_keys_str_mv AT attimaradm liquidchromatographicdeterminationofflavoxatehclinpharmaceuticalformulation